On the benefits of sin

Can greater understanding of the 1F7-idiotypic repertoire freeze enhance HIV vaccine development?

Matthew S. Parsons Research Institute of the McGill University Health Centre; Montréal, QC Canada; Division of Clinical Immunology and Allergy; McGill University Health Centre; Montréal, QC Canada; Division of Experimental Medicine; McGill University; Montréal, QC Canada

Sybille Muller Immpheron, Inc.; Lexington, KY USA

Heinz Kohler Department of Microbiology; Immunology & Molecular Genetics; University of Kentucky College of Medicine; Lexington, KY USA

Michael D. Grant Immunology and Infectious Diseases Program; Division of BioMedical Sciences, Faculty of Medicine; Memorial University of Newfoundland; St. John’s, NL Canada

Nicole F. Bernard Research Institute of the McGill University Health Centre; Montréal, QC Canada; Division of Clinical Immunology and Allergy; McGill University Health Centre; Montréal, QC Canada; Division of Experimental Medicine; McGill University; Montréal, QC CanadaCorrespondence[email protected]

On the benefits of sin

Can greater understanding of the 1F7-idiotypic repertoire freeze enhance HIV vaccine development?

Table 1. List of different types of anti-idiotypic antibodies

Information for

Open access

Opportunities

Help and information

Your download is now in progress and you may close this window

Login or register to access this feature

On the benefits of sin

Can greater understanding of the 1F7-idiotypic repertoire freeze enhance HIV vaccine development?

Figures & data

Table 1. List of different types of anti-idiotypic antibodies

Related research

To cite this article:

Download citation

Information for

Open access

Opportunities

Help and information

Keep up to date